A systematic review of Molly®’s integrated and flexible device design and development model.

Self-administered injectable medicines are a crucial part of home-based disease management and treatment. As the world accelerates towards new digital horizons and the promise of Healthcare 4.0, fresh perspectives on how to optimise device design and manufacturing are needed. SHL Medical’s Molly® family of autoinjector devices harnesses the power of modularity at all stages of the product life cycle to deliver a truly customisable and sustainable solution to the increasing need for self-administered parenteral medicaments. Learn more about SHL’s innovative approach to combination products built upon scalable platform-technologies. Download now to discover how their approach promises to play an integral part in the emerging paradigm shift.